Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial

por Keohane, Denis, Schwartz, Jeffrey, Gundapaneni, Balarama, Stewart, Michelle, Amass, Leslie
Publicado 2015

Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy

por Sultan, Marla B, Gundapaneni, Balarama, Schumacher, Jennifer, Schwartz, Jeffrey H
Publicado 2017

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

por Waddington Cruz, Márcia, Amass, Leslie, Keohane, Denis, Schwartz, Jeffrey, Li, Huihua, Gundapaneni, Balarama
Publicado 2016

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy

por Amass, Leslie, Li, Huihua, Gundapaneni, Balarama K., Schwartz, Jeffrey H., Keohane, Denis J.
Publicado 2018

Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy

por Waddington-Cruz, Marcia, Amass, Leslie, Keohane, Denis, Schwartz, Jeffrey, Gundapaneni, Balarama, Li, Hui Hua
Publicado 2015

Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR‐ACT

por Nativi‐Nicolau, Jose, Judge, Daniel P., Hoffman, James E., Gundapaneni, Balarama, Keohane, Denis, Sultan, Marla B., Grogan, Martha
Publicado 2021

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

por Shah, Sanjiv J., Fine, Nowell, Garcia-Pavia, Pablo, Klein, Allan L., Fernandes, Fabio, Weissman, Neil J., Maurer, Mathew S., Boman, Kurt, Gundapaneni, Balarama, Sultan, Marla B., Elliott, Perry
Publicado 2023

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study

por Damy, Thibaud, Garcia‐Pavia, Pablo, Hanna, Mazen, Judge, Daniel P., Merlini, Giampaolo, Gundapaneni, Balarama, Patterson, Terrell A., Riley, Steven, Schwartz, Jeffrey H., Sultan, Marla B., Witteles, Ronald
Publicado 2020

Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy

por Elliott, Perry, Drachman, Brian M., Gottlieb, Stephen S., Hoffman, James E., Hummel, Scott L., Lenihan, Daniel J., Ebede, Ben, Gundapaneni, Balarama, Li, Benjamin, Sultan, Marla B., Shah, Sanjiv J.
Publicado 2021